CareDx, Inc., a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced it will report financial results for the second quarter 2021 after market close on Thursday, July 29, 2021. Read More
China Launches the World’s Largest Real-World Study on Screening and Diagnosis of Male Reproduction-Related Genes
On July 3, 2021, the “Caring for Men’s Health” Charity Fund of the Chinese Primary Health Care Foundation…
Bryan Dechairo, newly appointed president and CEO of Sherlock Biosciences, learned early in his career to fill gaps…
Hyperfine, Inc., Creator of the First FDA-Cleared Portable MRI Device, and Liminal Sciences, Inc. To Be Listed on Nasdaq Through a Business Combination With HealthCor Catalio Acquisition Corp.
Hyperfine today announced their entry into a definitive business combination agreement with HealthCor Catalio Acquisition Corp. Read More